Business & Finance
Business and Finance
Business and Finance
Tue, October 25, 2011
Mon, October 24, 2011 BioMed Realty Trust to Report 2011 Third Quarter Results
BioMed Realty Trust to Report 2011 Third Quarter Results -- SAN DIEGO, Oct. 24, 2011 /PRNewswire/ --
BioMed Realty Trust to Report 2011 Third Quarter Results
SAN DIEGO, Oct. 24, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: [ BMR ]) today announced it will report results for its third quarter ended September 30, 2011 after the market closes on Tuesday, November 1, 2011.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Wednesday, November 2, 2011 to discuss the company's financial results and operations for the quarter.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at [ www.biomedrealty.com ] and at [ www.earnings.com ], which will include an online slide presentation to accompany the call, or live by calling 866-831-6270 (domestic) or 617-213-8858 (international) with call ID number 77227302. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Wednesday, November 2, 2011 until midnight Pacific Time on Monday, November 7, 2011 by calling 888-286-8010 (domestic) or 617-801-6888 (international) and using access code 10547121.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in properties comprising approximately 12.3 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. Additional information is available at [ www.biomedrealty.com ].
SOURCE BioMed Realty Trust, Inc.
[ Back to top ] RELATED LINKS
[ http://www.biomedrealty.com ]
